Previous Article | Next Article ![]()
Infection and Immunity, March 1999, p. 1079-1085, Vol. 67, No. 3
Clintec Technologies,
Received 29 June 1998/Returned for modification 2 November
1998/Accepted 1 December 1998
Most animal models of sepsis induced high mortality or early
recovery and do not mimic the long-lasting catabolic state observed in
patients. The purpose of this study is to develop a model of sepsis
which reproduces these disorders, especially the long-lasting muscle
wasting. This report summarizes our observations in a series of seven
experiments using this model with rats to study the route of live
Escherichia coli administration, dose of bacteria,
reproducibility of the model, bacterial count in tissues, comparison of
injection of live or dead bacteria, metabolic perturbations linked to
infection, and potential role of tumor necrosis factor alpha (TNF-
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
A Sustained Rat Model for Studying the
Long-Lasting Catabolic State of Sepsis
)
in muscle wasting. After intravenous infection, animals were anorexic
and the catabolic state was long-lasting: body weight loss for 2 to 3 days followed by a chronic wasting state for several days. Liver, spleen, lung protein content, and plasma concentration of
2-macroglobulin were increased 2 and 6 days after
infection. At 6 days, muscle protein content was substantially (
40%)
reduced. The plasma TNF-
level measured 1.5 h after infection
correlated with body weight loss observed 9 days later. The inhibition
of TNF-
secretion by administration of pentoxifylline 1 h
before infection reduced muscle wasting and activation of proteolysis
at day 2 and abolished them at day 6. This septic model mimics in rats
the prolonged protein metabolism alterations and muscle atrophy
characteristics of infected patients and thus is useful for studying
the impact of nutritional support on outcome.
*
Corresponding author. Mailing address: Laboratoire
d'Etude du Métabolisme Azoté, INRA Theix, 63122 Ceyrat,
France. Phone: (33) 04 73 62 42 10. Fax: (33) 04 73 62 47 55. E-mail:
Breuille{at}Clermont.inra.fr.
Infection and Immunity, March 1999, p. 1079-1085, Vol. 67, No. 3
0019-9567/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»